Literature DB >> 32068268

Down-regulation of FOXR2 inhibits hypoxia-driven ROS-induced migration and invasion of thyroid cancer cells via regulation of the hedgehog pathway.

Chong-Wu Liao1, Chen Zheng1, Le Wang2.   

Abstract

Forkhead box R2 (FOXR2), a new member of the FOX family, is involved in a wide range of biological processes such as embryogenesis, differentiation, transformation and metabolic homeostasis. Recently, FOXR2 has been reported to be aberrantly expressed in a variety of cancers and correlated with cancer development. However, the specific role of FOXR2 in thyroid cancer (TC) remains unclear. In this study, we showed that FOXR2 was highly expressed in TC tissues and cell lines. Moreover, down-regulation of FOXR2 inhibited hypoxia-induced reactive oxygen species (ROS) production and migration/invasion of TC cells. We also found that the hedgehog pathway was responsible for the partial mechanisms underlying the inhibitory effect. Taken together, these findings indicated that down-regulation of FOXR2 inhibits hypoxia-driven ROS-induced migration and invasion of TC cells via regulation of the hedgehog pathway. Thus, FOXR2 may hold great potential for TC treatment.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  FOXR2; hypoxia; invasion; migration; thyroid cancer

Mesh:

Substances:

Year:  2020        PMID: 32068268     DOI: 10.1111/1440-1681.13286

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Mir-326 potentiates radiosensitivity of cervical squamous cell carcinoma through downregulating SMO expression in the Hedgehog signaling pathway.

Authors:  Junqin Zhang; Yaxing Li; Yanan Ren; Hua Han; Jie Li
Journal:  Genes Genomics       Date:  2022-06-25       Impact factor: 2.164

2.  Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.

Authors:  Tshering D Lama-Sherpa; Shamik Das; Dominique C Hinshaw; Sarah C Kammerud; Patrick N Song; Heba A Alsheikh; Anna G Sorace; Rajeev S Samant; Lalita A Shevde
Journal:  Mol Cancer Res       Date:  2021-09-30       Impact factor: 6.333

Review 3.  LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer.

Authors:  Qiudan Zhang; Jinze Shen; Yuchen Wu; Wenjing Ruan; Feng Zhu; Shiwei Duan
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.